Boston Therapeutics, Inc.
BTHE · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $7 | $12 | $137 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $2 | $4 | $1 | $39 |
| Other Curr. Assets | $10 | $13 | $908 | $215 |
| Total Curr. Assets | $20 | $23 | $922 | $391 |
| Property Plant & Equip (Net) | $0 | $1 | $2 | $4 |
| Goodwill | $0 | $0 | $0 | $70 |
| Intangibles | $0 | $0 | $515 | $439 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $1 | $517 | $513 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $20 | $24 | $1,439 | $904 |
| Liabilities | – | – | – | – |
| Payables | $531 | $610 | $510 | $299 |
| Short-Term Debt | $4,835 | $4,050 | $2,830 | $2,502 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $105 | $105 | $105 | $105 |
| Other Curr. Liab. | $3,129 | $2,930 | $1,215 | $782 |
| Total Curr. Liab. | $8,600 | $7,696 | $4,659 | $3,688 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $926 | $1,099 |
| Total NC Liab. | $0 | $0 | $926 | $1,099 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $8,600 | $7,696 | $5,585 | $4,787 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $111 | $111 | $110 | $64 |
| Retained Earnings | -$28,014 | -$27,106 | -$23,412 | -$19,811 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $19,323 | $19,323 | $19,156 | $15,863 |
| Total Equity | -$8,580 | -$7,672 | -$4,146 | -$3,884 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $20 | $24 | $1,439 | $904 |
| Net Debt | $4,828 | $4,044 | $2,817 | $2,365 |